10 October 2025
Harena Resources Plc
("Harena" or the "Company")
Media Interview Now Available Online
Harena Resources Plc (LSE: HREE), the rare earths company developing the Ampasindava Ionic Clay Rare Earth Project in Madagascar, is pleased to share a recent media interview featuring Executive Chairman Ivan Murphy.
The interview covers key updates on:
| • | Progress toward the Pre-Feasibility Study (PFS) submission |
| • | Strategy for securing a full Mining Licence in Madagascar |
| • | Recent £450,000 investment from RAB Capital |
| • | Escalating global trade tensions over rare earths |
| • | Harena's positioning as a non-Chinese source of magnet metals |
Media Link:
Proactive Investors Interview with Ivan Murphy
Ivan outlines the strategic roadmap for Harena and the broader market context
https://www.youtube.com/watch?v=EL4EiyUcG1Q
For further information please contact:
| Harena Resources Plc Allan Mulligan, Executive Technical Director
|
+44 (0)20 7770 6424 LEI: 213800TNHZOA4JIZK687 |
|
Allenby Capital Limited - Financial Adviser & Joint Broker Jeremy Porter / Vivek Bhardwaj (Corporate Finance) Amrit Nahal / Kelly Gardiner (Sales & Corporate Broking)
|
+44 (0)20 3328 5656 |
| Tavira Financial Limited - Joint Broker Jonathan Evans / Oliver Stansfield
|
+44 (0)20 7330 1833 |
| Celicourt Communications - Public Relations Mark Antelme / Charles Denley-Myerson | 44 (0)20 7770 6424 celicourt@celicourt.uk |
Notes to editors
Harena (www.harenaresources.com.au) is a rare earths exploration and development company focused on the Ampasindava Ionic Clay Rare Earth Project in Madagascar (Harena's interest is 75%). The project hosts one of the largest ionic clay rare earth deposits outside of China, with significant concentrations of high-value magnet metals. Harena is committed to low-impact, high recovery mining, providing a sustainable supply of critical minerals for the global energy transition and military defence industries. Forward-Looking Statements This announcement contains forward-looking statements that involve risks and uncertainties. Actual results may differ materially from those expressed or implied in such statements.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.